col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


53 Results       Page 1

 [1] 
Elsevier: Journal of Autoimmunity
  original article Date Title Authors   All Authors
1 [GO] 2022―Apr―14 Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong Xue Li, Le Gao, Xinning Tong, Vivien K.Y. Chan, Celine S.L. Chui, Francisco T.T. Lai, et al. (+6)
2 [GO] 2022―Apr―11 High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients Martina Fabris, Ginevra De Marchi, Rossana Domenis, Federica Caponnetto, Silvia Guella, Chiara Dal Secco, et al. (+5)
3 [GO] 2022―Feb―24 Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature Hayri Bostan, Bekir Ucan, Muhammed Kizilgul, Murat Calapkulu, Sema Hepsen, Umran Gul, et al. (+2)
4 [GO] 2022―Jan―01 Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy Azizul Haque, Anudeep B. Pant
5 [GO] 2021―Dec―28 Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination G. Fiorillo, S. Pancetti, A. Cortese, F. Toso, S. Manara, A. Costanzo, R.G. Borroni
6 [GO] 2021―Dec―14 Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence? Shotaro Tabata, Hiroki Hosoi, Shogo Murata, Satomi Takeda, Toshiki Mushino, Takashi Sonoki
7 [GO] 2021―Dec―13 Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies Saathvik R. Kannan, Austin N. Spratt, Kalicharan Sharma, Hitendra S. Chand, Siddappa N. Byrareddy, Kamal Singh
8 [GO] 2021―Dec―06 Ferritin - from iron, through inflammation and autoimmunity, to COVID-19 Naim Mahroum, Amal Alghory, Zeynep Kiyak, Abdulkarim Alwani, Ravend Seida, Mahmoud Alrais, Yehuda Shoenfeld
9 [GO] 2021―Nov―11 Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up? Enver Avci, Fatma Abasiyanik
10 [GO] 2021―Nov―10 Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups Clodoveo Ferri, Francesco Ursini, Laura Gragnani, Vincenzo Raimondo, Dilia Giuggioli, Rosario Foti, et al. (+42)
11 [GO] 2021―Oct―28 A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases Athanasios G. Tzioufas, Athanasios-Dimitrios Bakasis, Andreas V. Goules, Kleopatra Bitzogli, Ilir I. Cinoku, Loukas G. Chatzis, et al. (+18)
12 [GO] 2021―Oct―28 Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study Bente Mertz Nørgård, Floor Dijkstra Zegers, Jan Nielsen, Jens Kjeldsen
13 [GO] 2021―Oct―27 Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence Isabel Garrido, Susana Lopes, Manuel Sobrinho Simões, Rodrigo Liberal, Joanne Lopes, Fátima Carneiro, Guilherme Macedo
14 [GO] 2021―Oct―26 Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data Luigi Cari, Mahdieh Naghavi Alhosseini, Paolo Fiore, Sabata Pierno, Sabrina Pacor, Alberta Bergamo, et al. (+2)
15 [GO] 2021―Oct―13 A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination Armando Patrizio, Silvia Martina Ferrari, Alessandro Antonelli, Poupak Fallahi
16 [GO] 2021―Oct―12 Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network Rahul Raiker, Haig Pakhchanian, Charles DeYoung, Latika Gupta, Sinan Kardeş, Sakir Ahmed, Chengappa Kavadichanda
17 [GO] 2021―Sep―27 Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination Massimo Cugno, Paolo Macor, Mara Giordano, Marcello Manfredi, Samantha Griffini, Elena Grovetti, et al. (+9)
18 [GO] 2021―Aug―11 Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses Saathvik R. Kannan, Austin N. Spratt, Alisha R. Cohen, S. Hasan Naqvi, Hitendra S. Chand, Thomas P. Quinn, et al. (+3)
19 [GO] 2021―Jul―28 Autoimmune hepatitis triggered by SARS-CoV-2 vaccination Élise Vuille-Lessard, Matteo Montani, Jaume Bosch, Nasser Semmo
20 [GO] 2021―Jul―27 Thrombocytopenia after COVID-19 vaccination Kristian Kragholm, Maurizio Sessa, Thomas Mulvad, Mikkel Porsborg Andersen, Helle Collatz-Christensen, Stig Nikolaj Blomberg, et al. (+8)
21 [GO] 2021―Jul―20 Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study Mar Masiá, Marta Fernández-González, Guillermo Telenti, Vanesa Agulló, José A. García, Sergio Padilla, et al. (+4)
22 [GO] 2021―Jul―16 COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Kyriaki A. Boki, Athanasios G. Tzioufas, Panayiotis G. Vlachoyiannopoulos, Ioanna E. Stergiou, et al. (+2)
23 [GO] 2021―Jul―15 Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity? Michele Ghielmetti, Helen Dorothea Schaufelberger, Giorgina Mieli-Vergani, Andreas Cerny, Eric Dayer, Diego Vergani, Benedetta Terziroli Beretta-Piccoli
24 [GO] 2021―Jun―23 Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data Luigi Cari, Paolo Fiore, Mahdieh Naghavi Alhosseini, Gianni Sava, Giuseppe Nocentini
25 [GO] 2021―Jun―21 Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals Holger Lingel, Stefan Meltendorf, Ulrike Billing, Christoph Thurm, Katrin Vogel, Christiane Majer, et al. (+7)
26 [GO] 2021―Jun―15 Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines Jimin Hwang, Se Bee Lee, Seung Won Lee, Min Ho Lee, Ai Koyanagi, Louis Jacob, et al. (+4)
27 [GO] 2021―Jun―11 Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19 Ana I. Rodriguez-Perez, Carmen M. Labandeira, Maria A. Pedrosa, Rita Valenzuela, Juan A. Suarez-Quintanilla, María Cortes-Ayaso, et al. (+2)
28 [GO] 2021―May―19 Differences in venous immunothrombosis in severe COVID-19 pneumonia and Vaccine-Induced Thrombotic Thrombocytopenia (VITT) - It's in the viral DNA Dennis McGonagle, Gabriele De Marco, Charles Bridgewood
29 [GO] 2021―May―01 A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine Haralampos M. Moutsopoulos
30 [GO] 2021―Apr―30 Corrigendum to “Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19” [J. Autoimmun. 117C (2020) 102595] Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, et al. (+6)
31 [GO] 2021―Apr―27 An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 Julia Y. Wang, Wei Zhang, Michael W. Roehrl, Victor B. Roehrl, Michael H. Roehrl
32 [GO] 2021―Mar―26 Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark Jens Kjeldsen, Jan Nielsen, Torkell Ellingsen, Torben Knudsen, Rasmus Gaardskær Nielsen, Michael Due Larsen, et al. (+2)
33 [GO] 2021―Feb―15 Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study Mohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, Mads Damsgaard Wewer, Laura Kirstine Vinther Arp, Melek Zahra Sarikaya, et al. (+4)
34 [GO] 2021―Jan―22 COVID-19 convalescent plasma composition and immunological effects in severe patients Yeny Acosta-Ampudia, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Juan Esteban Gallo, Juan Carlos Salazar-Uribe, et al. (+9)
35 [GO] 2021―Jan―15 Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status Yonggang Zhou, Jinhe Zhang, Dongyao Wang, Dong Wang, Wuxiang Guan, Jingkun Qin, et al. (+11)
36 [GO] 2021―Jan―12 Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19 Luca Valenti, Samantha Griffini, Giuseppe Lamorte, Elena Grovetti, Sara Colonia Uceda Renteria, Francesco Malvestiti, et al. (+6)
37 [GO] 2020―Dec―16 The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature Lucia Novelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, M. Eric Gershwin, Carlo Selmi
38 [GO] 2020―Nov―30 A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center Juan C. Sarmiento-Monroy, Gerard Espinosa, Maria-Carlota Londoño, Fernanda Meira, Berta Caballol, Sara Llufriu, et al. (+28)
39 [GO] 2020―Oct―30 Complement activation and endothelial perturbation parallel COVID-19 severity and activity Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, et al. (+17)
40 [GO] 2020―Aug―20 High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients Enrique Iglesias Julián, María López Veloso, Noelia de la Torre Ferrera, Julio Cesar Barraza Vengoechea, Pedro David Delgado-López, María Colazo Burlato, et al. (+9)
41 [GO] 2020―Jul―16 Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study Oscar Moreno-Pérez, Mariano Andres, Jose-Manuel Leon-Ramirez, José Sánchez-Payá, Juan Carlos Rodríguez, Rosario Sánchez, et al. (+4)
42 [GO] 2020―Jul―08 Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients Lorenzo M. Canziani, Serena Trovati, Enrico Brunetta, Amidio Testa, Maria De Santis, Emilio Bombardieri, et al. (+17)
43 [GO] 2020―Jul―03 Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab Austin R. Morrison, Joseph M. Johnson, Kristin M. Griebe, Mathew C. Jones, John J. Stine, Laura N. Hencken, et al. (+7)
44 [GO] 2020―Jun―16 Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, Maria De Santis, Yeny Acosta-Ampudia, Diana M. Monsalve, et al. (+7)
45 [GO] 2020―Jun―08 SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients M. Zen, E. Fuzzi, D. Astorri, F. Saccon, R. Padoan, L. Ienna, et al. (+17)
46 [GO] 2020―May―16 Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434] Yongshi Yang, Fujun Peng, Runsheng Wang, Ming Yang, Kai Guan, Taijiao Jiang, et al. (+3)
47 [GO] 2020―Apr―24 Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience Ying Sun, Yanli Dong, Lifeng Wang, Huan Xie, Baosen Li, Christopher Chang, Fu-sheng Wang
48 [GO] 2020―Apr―17 The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 Carlo Perricone, Paola Triggianese, Elena Bartoloni, Giacomo Cafaro, Angelo F. Bonifacio, Roberto Bursi, et al. (+2)
49 [GO] 2020―Apr―13 Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 Guoping Li, Xiang He, Lei Zhang, Qin Ran, Junyi Wang, Anying Xiong, et al. (+4)
50 [GO] 2020―Apr―10 Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? Bingwen Liu, Min Li, Zhiguang Zhou, Xuan Guan, Yufei Xiang
51 [GO] 2020―Apr―02 Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy Angela Ceribelli, Francesca Motta, Maria De Santis, Aftab A. Ansari, William M. Ridgway, M. Eric Gershwin, Carlo Selmi
52 [GO] 2020―Mar―03 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China Yongshi Yang, Fujun Peng, Runsheng Wang, Kai Guan, Taijiao Jiang, Guogang Xu, et al. (+2)
53 [GO] 2020―Feb―26 The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak Hussin A. Rothan, Siddappa N. Byrareddy
 [1] 

53 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec